90 related articles for article (PubMed ID: 7693056)
1. Effects of an anti-CD5 immunoconjugate (CD5-plus) in recent onset type I diabetes mellitus: a preliminary investigation. The CD5 Diabetes Project Team.
Skyler JS; Lorenz TJ; Schwartz S; Eisenbarth GS; Einhorn D; Palmer JP; Marks JB; Greenbaum C; Saria EA; Byers V
J Diabetes Complications; 1993; 7(4):224-32. PubMed ID: 7693056
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of anti-CD5 ricin A chain immunoconjugate in systemic lupus erythematosus.
Stafford FJ; Fleisher TA; Lee G; Brown M; Strand V; Austin HA; Balow JE; Klippel JH
J Rheumatol; 1994 Nov; 21(11):2068-70. PubMed ID: 7532717
[TBL] [Abstract][Full Text] [Related]
3. Administration of an anti-CD5 immunoconjugate to patients with rheumatoid arthritis: effect on peripheral blood mononuclear cells and in vitro immune function.
Fishwild DM; Strand V
J Rheumatol; 1994 Apr; 21(4):596-604. PubMed ID: 7518519
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of an anti-CD5-ricin A chain immunoconjugate in an improved human peripheral blood lymphocyte--reconstituted severe combined immunodeficient mouse model.
Kohn FR; Fishwild DM; Kung AH
Int J Immunopharmacol; 1993 Aug; 15(6):695-709. PubMed ID: 7691766
[TBL] [Abstract][Full Text] [Related]
5. Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group.
Strand V; Lipsky PE; Cannon GW; Calabrese LH; Wiesenhutter C; Cohen SB; Olsen NJ; Lee ML; Lorenz TJ; Nelson B
Arthritis Rheum; 1993 May; 36(5):620-30. PubMed ID: 7683881
[TBL] [Abstract][Full Text] [Related]
6. Investigation and prevention of artifactual staining in flow cytometric analyses of whole blood samples from patients treated with H65-RTA, an anti-CD5 monoclonal antibody conjugated to ricin A chain.
Fishwild DM; Saria EA
J Immunol Methods; 1991 Nov; 144(1):27-34. PubMed ID: 1720441
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.
Fishwild DM; Aberle S; Bernhard SL; Kung AH
Cancer Res; 1992 Jun; 52(11):3056-62. PubMed ID: 1375534
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma.
LeMaistre CF; Rosen S; Frankel A; Kornfeld S; Saria E; Meneghetti C; Drajesk J; Fishwild D; Scannon P; Byers V
Blood; 1991 Sep; 78(5):1173-82. PubMed ID: 1878584
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusion.
Shah SA; Lambert JM; Goldmacher VS; Esber HJ; Levin JL; Chungi V; Zutshi A; Braman GM; Ariniello PD; Taylor JA
Int J Immunopharmacol; 1993 Aug; 15(6):723-36. PubMed ID: 7691767
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD3 immunotoxin prevents low-dose STZ/interferon-induced autoimmune diabetes in mouse.
Vallera DA; Carroll SF; Brief S; Blazar BR
Diabetes; 1992 Apr; 41(4):457-64. PubMed ID: 1376702
[TBL] [Abstract][Full Text] [Related]
11. Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2.
Better M; Bernhard SL; Lei SP; Fishwild DM; Lane JA; Carroll SF; Horwitz AH
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):457-61. PubMed ID: 7678457
[TBL] [Abstract][Full Text] [Related]
12. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of anti-CD5 ricin A chain immunoconjugate for prevention of acute graft-vs.-host disease after HLA-identical marrow transplantation.
Przepiorka D; LeMaistre CF; Huh YO; Luna M; Saria EA; Brown CT; Champlin RE
Ther Immunol; 1994 Apr; 1(2):77-82. PubMed ID: 7584486
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment of kidney allografts with anti-CD5 immunotoxin: a new chance for high responder recipients.
Alexeev LP; Toptygin AYu ; Korenkova EV; Yan G Moisiuk Y; Muromtseva IB; Tonevitsky AG; Dolbin AG; Sechkin AV; Shumakov VI; Vasilov RG; Khaitov RM
Transplant Proc; 1997 Dec; 29(8):3605-6. PubMed ID: 9414856
[No Abstract] [Full Text] [Related]
15. Insulin secretion in type 1 diabetes.
Steele C; Hagopian WA; Gitelman S; Masharani U; Cavaghan M; Rother KI; Donaldson D; Harlan DM; Bluestone J; Herold KC
Diabetes; 2004 Feb; 53(2):426-33. PubMed ID: 14747294
[TBL] [Abstract][Full Text] [Related]
16. The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxins.
Manske JM; Buchsbaum DJ; Vallera DA
J Immunol; 1989 Mar; 142(5):1755-66. PubMed ID: 2465347
[TBL] [Abstract][Full Text] [Related]
17. Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model.
Chignola R; Pasti M; Candiani C; Franceschi A; Anselmi C; Tridente G; Colombatti M
Int J Cancer; 1995 May; 61(4):535-41. PubMed ID: 7538979
[TBL] [Abstract][Full Text] [Related]
18. GAD treatment and insulin secretion in recent-onset type 1 diabetes.
Ludvigsson J; Faresjö M; Hjorth M; Axelsson S; Chéramy M; Pihl M; Vaarala O; Forsander G; Ivarsson S; Johansson C; Lindh A; Nilsson NO; Aman J; Ortqvist E; Zerhouni P; Casas R
N Engl J Med; 2008 Oct; 359(18):1909-20. PubMed ID: 18843118
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo depletion of human bone marrow T lymphocytes by soybean lectin fractionation followed by treatment with an anti-pan-T cell (CD5) ricin A- chain immunotoxin.
Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
Transplant Proc; 1987 Feb; 19(1 Pt 3):2735-7. PubMed ID: 3274583
[No Abstract] [Full Text] [Related]
20. Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease.
Antin JH; Bierer BE; Smith BR; Guinan EC; Provost MM; Ferrara J; Macklis RM; Tarbell NJ; Blythman H; Bouloux C
Prog Clin Biol Res; 1990; 333():207-15. PubMed ID: 1689852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
